ReviewAntioxidants (Basel, Switzerland)2025
Dietary Supplements Derived from Food By-Products for the Management of Diabetes Mellitus.
Review in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rising global incidence of diabetes has heightened the demand for prevention strategies that are both effective and environmentally sustainable. In this context, dietary supplements obtained from food processing by-products have emerged as promising candidates, combining high nutritional value with the potential to reduce food waste. These by-products contain abundant bioactive compounds, such as antioxidants, dietary fiber, vitamins, and minerals, that have been associated with improved glycemic regulation. Their beneficial effects are mediated through several interconnected biological mechanisms, including enhanced insulin sensitivity, attenuation of oxidative stress, and modulation of inflammatory pathways. The efficacy of these supplements is supported by findings from preclinical models, clinical trials, and meta-analyses, which also allow comparison with standard antidiabetic interventions. Alongside these findings, considerations related to safety, toxicity, and the regulatory framework are critical for their integration into preventive health strategies. Furthermore, market trends, technological challenges in supplement formulation, and ethical issues surrounding the valorization of food waste are key factors influencing their development and acceptance. Together, these insights underscore the dual therapeutic and ecological potential of food by-product-derived supplements in diabetes prevention, while identifying essential avenues for future research and innovation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.